Zengpanpan Ye

Zengpanpan Ye

Auto-generated profile, based on publicly available information

Zengpanpan Ye

Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Department of Neurosurgery, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, P. R. China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2023 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
ZYZengpanpan Ye
Zengpanpan Ye
XAXiaolin Ai
Xiaolin Ai
KYKailin Yang
Kailin Yang
ZYZhengnan Yang
Zhengnan Yang
FFFan Fei
Fan Fei
SZShengtao Zhou
Shengtao Zhou
Glioblastoma (GBM) constitutes the most lethal primary brain tumor for which immunotherapy has provided limited benefit. The unique brain immune landscape is reflected in a complex tumor immune microenvironment (TIME) in GBM. Here, single-cell sequencing of the GBM TIME revealed that microglia were under severe oxidative stress, which induced nuclear receptor subfamily 4 group A member 2 (NR4A2)–dependent transcriptional activity in microglia. Heterozygous Nr4a2 (Nr4a2+/−) or CX3CR1+ myeloid cell–specific Nr4a2 (Nr4a2fl/flCx3cr1Cre) genetic targeting reshaped microglia plasticity in vivo by reducing alternatively activated microglia and enhancing antigen presentation capacity for CD8+ T cells in GBM. In microglia, NR4A2 activated squalene monooxygenase (SQLE) to dysregulate cholesterol homeostasis. Pharmacologic NR4A2 inhibition attenuated the protumorigenic TIME, and targeting the NR4A2 or SQLE enhanced the therapeutic efficacy of immune-checkpoint blockade in vivo. Collectively, oxidative stress promotes tumor growth through NR4A2–SQLE activity in microglia, informing novel immune therapy paradigms in brain cancer. Significance: Metabolic reprogramming of microglia in GBM informs synergistic vulnerabilities for immune-checkpoint blockade therapy in this immunologically cold brain tumor. This article is highlighted in the In This Issue feature, p. 799

26 April 2022 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
XAXiaolin Ai
Xiaolin Ai
ZYZengpanpan Ye
Zengpanpan Ye
CXChaoxin Xiao
Chaoxin Xiao
JZJian Zhong
Jian Zhong
JLJoseph J. Lancman
Joseph J. Lancman
CZChengjian Zhao
Chengjian Zhao
An accurate prediction of the intracranial infiltration tendency and drug response of individual glioblastoma (GBM) cells is essential for personalized prognosis and treatment for this disease. However, the clinical utility of mouse patient-derived orthotopic xenograft (PDOX) models remains limited given current technical constraints, including difficulty in generating sufficient sample numbers from small tissue samples and a long latency period for results. To overcome these issues, we established zebrafish GBM xenografts of diverse origin, which can tolerate intracranial engraftment and maintain their unique histological features. Subsequent single-cell RNA-sequencing (scRNA-seq) analysis confirmed significant transcriptional identity to that of invading GBM microtumors observed in the proportionally larger brains of model animals and humans. Endothelial scRNA-seq confirmed that the zebrafish blood–brain barrier is homologous to the mammalian blood–brain barrier. Finally, we established a rapid and efficient zebrafish PDOX (zPDOX) model, which can predict long-term outcomes of GBM patients within 20 days. The zPDOX model provides a novel avenue for precision medicine of GBM, especially for the evaluation of intracranial infiltration tendency and prediction of individual drug sensitivity.

3 April 2018 in Neurology
Verified
Journal Article
Closed access
PDF file
JZJun Zheng
Jun Zheng
ZYZengpanpan Ye
Zengpanpan Ye
CYChao You
Chao You
We read with interest the article by Liotta et al.,1 in which lower admission serum magnesium (ASM) was associated with worse outcomes in spontaneous intracerebral hemorrhage (SICH). We reevaluated the prognostic role of ASM in 395 SICH patients in the West China Hospital during 2011 and 2016: 269 male (68.1%), mean age of 57.63 (13.06) years, hematoma volume of 25.599 (25.452) mL, Glasgow Coma Scale (GCS) of 12, and ASM of 2.030 (0.368) mg/dL. With t tests, 91 patients with favorable outcomes had higher ASM levels (2.111 [0.438] vs 2.006 [0.341] mg/dL, p = 0.016); lower ASM levels were found in 97 patients who died within 30 days (2.062 [0.387] vs 1.931 [0.279] mg/dL, p = 0.002). After adjusting for the factors seen in Liotta et al., the GCS (odds ratio [OR] 0.711, 95% confidence interval [CI] 0.652–0.777, p < 0.001), hematoma volume (OR 1.012, 95% CI 1.000–1.025, p = 0.049), hematoma volume change (OR 2.102, 95% CI, 1.637–2.699, p < 0.001), and ASM (OR 0.673, 95% CI, 0.490–0.924, p = 0.015) were associated with 30-day mortality. Moreover, the GCS (OR 0.642, 95% CI 0.554–0.744, p < 0.001) and hematoma volume (OR 1.034, 95% CI 1.013–1.056, p = 0.001) were associated with 3-month outcomes, which kept with previous studies.1–3 However, ASM was not a predictor for 3-month outcomes (OR 0.519, 95% CI 0.099–2.713, p = 0.437). Therefore, our findings add new and important data (i.e., ASM is associated with 30-day mortality) to the literature. However, the association of ASM and 3-month outcomes needs further study.

3 April 2023
Verified
Other
Open access
ZYZengpanpan Ye
Zengpanpan Ye
XAXiaolin Ai
Xiaolin Ai
KYKailin Yang
Kailin Yang
ZYZhengnan Yang
Zhengnan Yang
FFFan Fei
Fan Fei
SZShengtao Zhou
Shengtao Zhou
Table S3 describes primer information for qPCR analysis.

4 April 2023
Verified
Other
Open access
ZYZengpanpan Ye
Zengpanpan Ye
XAXiaolin Ai
Xiaolin Ai
KYKailin Yang
Kailin Yang
ZYZhengnan Yang
Zhengnan Yang
FFFan Fei
Fan Fei
SZShengtao Zhou
Shengtao Zhou
Table S1 describes glioma patients and tissue samples information for evaluating the relationship of oxidative stress in microglia and prognosis

4 April 2023
Verified
Other
Open access
ZYZengpanpan Ye
Zengpanpan Ye
XAXiaolin Ai
Xiaolin Ai
KYKailin Yang
Kailin Yang
ZYZhengnan Yang
Zhengnan Yang
FFFan Fei
Fan Fei
SZShengtao Zhou
Shengtao Zhou
Table S1 describes glioma patients and tissue samples information for evaluating the relationship of oxidative stress in microglia and prognosis